ClinicalTrialsFinder

Recurrent Group 4 (Non-SHH/Non-WNT) Medulloblastoma Clinical Trials in Gainesville, Florida

1 recruitingGainesville, Florida

Showing 1–1 of 1 trials

Recruiting
Phase 1

Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma

Recurrent Group 3 MedulloblastomaRecurrent Group 4 (Non-SHH/Non-WNT) Medulloblastoma
University of Florida12 enrolled1 locationNCT06514898